News ABL Diagnostics

Equities

ABLD

FR001400AHX6

Real-time Euronext Paris Other stock markets 05:30:22 2024-05-20 am EDT			5-day change	1st Jan Change
3.04 ^EUR	0.00%		-0.65%	-68.66%

2023	ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ABL Diagnostics and Laborama officially appointed to offer NGS genotyping solutions to the National Laboratory for Public Health (NLPH) in Lithuania.	May. 13	AQ
AdvancedDx Biological Laboratories USA Inc. and Medline Industries, LP to distribute Next Generation Sequencing (NGS) Prep Kits in the U.S.	Apr. 17	AQ
AdvancedDx Biological Laboratories USA Inc. expands its logistics and storage capacity for supporting and managing third-parties' clinical trials in the USA	Apr. 16	AQ
ABL Diagnostics appoints PALEX to offer NGS genotyping applications & Sanger to microbiology laboratories in Spain.	Mar. 18	AQ
Block trading of ABL Diagnostics ordinary shares (ABLD, Euronext, compartment B)	Mar. 04	AQ
Carrying Out Research About HIV Whole Genome using a Kit Now Available in the USA	Feb. 28	AQ
ABL Diagnostics and AB ANALITICA join forces to offer microbiology genotyping solutions in Italy.	Feb. 28	AQ
AdvancedDx Biological Laboratories USA Inc. announces its new temperature-controlled warehouse in the USA	Feb. 20	AQ
ABL Diagnostics announces the release of its DeepChek®-HPV Assay, to be used for Human Papillomavirus screening, genotyping, and discrimination through sequencing.	Jan. 18	AQ
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	Dec. 21	CI
ABL DIAGNOSTICS INTRODUCING CRISPRCHEK - A NEW LINE OF ASSAYS USING THE CRISPR TECHNOLOGY	Dec. 18	AQ
ABL Diagnostics releases new applications for respiratory viruses including Influenza, RSV and SARS-CoV-2	Dec. 06	AQ
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	Nov. 30	AQ
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.	Nov. 24	AQ
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-07-31	CI
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa	23-03-27	MT
Roche Diagnostics (Pty) Ltd and ABL Diagnostics enter into an Exclusive Distribution Agreement in South Africa	23-03-27	AQ
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-01	CI
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.	22-08-30	CI
ABL Diagnostics : New Distribution Partnership in Ethiopia & Bolivia	22-06-09	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ABL Diagnostics

Equities

ABLD

FR001400AHX6

Summary

Filters